WOBURN, USA/ DARMSTADT, Germany – July 6, 2022
exocad announced that exoplan 3.0 Galway, the latest version of its implant planning software, is now U.S. Food and Drug Administration (FDA)- cleared and available for use in the United States. The new release supports the planning of edentulous cases, including the design of surgical guides.
